European committee takes a second look at Alzheimer's drug
ScienceAlert on MSN12h
Brain Autopsies Reveal a Potential New Culprit Behind Alzheimer'sUniversity of Washington-led research, published in 2023, discovered microglia in the brains of people with Alzheimer's ...
A breakthrough in the fight against Alzheimer’s disease may have been made in Seattle. Researchers at the Allen Institute ...
Biogen’s stock rose 1% Thursday, after Europe’s pharmaceutical regulator issued a positive opinion on the Alzheimer’s disease ...
An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...
The European Union's drugs regulator on Thursday recommended approval of Eisai and Biogen's Leqembi for some patients with ...
2don MSNOpinion
Alzheimer’s disease robs patients of so much more than their health. It can rewire their personalities and undermine a ...
Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling ...
As we count down toward the December readout of Cassava Sciences’ simufilam Phase 3 clinical trial in Alzheimer’s disease, ...
November is National Alzheimer’s Disease Month, and it’s also Caretaker Month. These two things often go hand-in-hand, but ...
The AD risk factors/hits include high exposure to traffic-related air pollution (TRAP) and infections, as well as factors ...
A multitude of genes have been linked to the development of Alzheimer's disease. Specifically how those genes might influence ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback